Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

PCMA: Ohio's Medicaid Program Could Save $135 Million

January 31, 2011 10:37 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Jan. 31, 2011 /PRNewswire-USNewswire/ -- Ohio's Medicaid program could cost taxpayers an additional $1.6 billion next year, a 49 percent jump in the state's share of costs for the health care program covering more than 2 million poor and disabled Ohioans, according to new...

New Interim Leadership for USP-Brazil

January 31, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Jan. 31, 2011 /PRNewswire-USNewswire/ -- To further its continuing partnerships with Brazilian public health authorities and pharmaceutical manufacturers, the U.S. Pharmacopeial Convention (USP) has appointed Mr. Nelson dos Santos as interim vice president of its Sao...

PDI to Present at the UBS 21st Annual Global Healthcare Services Conference

January 31, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Jan. 31, 2011 /- PDI, Inc. (Nasdaq: PDII ) today announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 3:30 pm ET on February 8, 2011 at the Grand Hyatt New York. The...

Advertisement

Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SANTA FE, N.M. and PRINCETON, N.J., Jan. 31, 2011 /- Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry, today announced the appointments of Ted Pine and Devon Reimer as Vice Presidents of Business Development, and...

Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SHAWNEE, Kan., Jan. 31, 2011 /- Bayer Animal Health announced this month at the North American Veterinary Conference, the availability of its new products:  Advantage® II for cats and dogs, and K9 Advantix® II for dogs.  These products combine the adulticidal...

Amarin Provides 2010 Year-End Review to Shareholders

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., Jan. 31, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today issued a special letter to its shareholders. The text of the letter, written by Joseph S. Zakrzewski, Executive...

ClinOps to Change Name to Emphusion

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Jan. 31, 2011 /- ClinOps is a specialized contract research organization with a core service offering combining expert data management, biostatistics and specialized clinical services. Emphusion targets development programs in biotechnology, medical device, and...

Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.

January 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 31, 2011 /- Laureate Pharma, Inc. has changed its name to Laureate Biopharmaceutical Services, Inc. (Laureate Biopharma) to better describe the company's positioning in the biopharmaceutical industry.  The company's logo has been updated to emphasize "Laureate"...

Advertisement

Endologix Announces Favorable Clinical Results for Nellix Technology

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Jan. 31, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm (EVAR)....

Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

GREENWICH, Conn., Jan. 31, 2011 /- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca®...

Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Jan. 31, 2011 /- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and...

Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

January 31, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Jan. 31, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic...

Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification

January 30, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 31, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc.,  have received a Paragraph IV Certification Notice from Mylan Technologies Inc. advising of the filing of an Abbreviated...

Advertisement

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011

January 30, 2011 1:31 pm | by Bio-Medicine.Org | News | Comments

DETROIT, Jan. 30, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for...

Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.

January 28, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

DENVER, Jan. 28, 2011 /- Burg Simpson Eldredge Hersh & Jardine, P.C., one of the nation's leading plaintiff litigation law firms, is delighted to announce that shareholder, Seth. A. Katz, has been appointed by the Hon. David A. Katz to serve as a member of the Plaintiffs' Steering...

Physiotherapy Associates Announces New Clinic in Castle Rock, CO

January 28, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

EXTON, Penn., Jan. 28, 2011 /- Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces a new clinic location in Castle Rock, CO. The clinic offers a comprehensive range of physical therapy services, including: orthopedics; back and neck...

Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association

January 28, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

FAIRFIELD, N.J., Jan. 28, 2011 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) announced that its 2011 "Woman of the Year" is Freda Lewis-Hall, MD, chief medical officer of Pfizer. In her distinguished 30-year career, Dr. Lewis-Hall has held leadership...

VirtualScopics Schedules Fourth Quarter/Full Year 2010 Earnings Announcement

January 28, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Jan. 28, 2011 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, today announced that before the market opens on Thursday, February 24, 2011 it will release its fourth quarter and full year 2010 financial results. The...

TechniScan to Present Live, Online at RetailInvestorConferences.com on February 3rd

January 28, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Jan. 28, 2011 /- TechniScan (OTC Bulletin Board: TSNI ), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, today announced that Dave Robinson, Chief Executive Officer, will present at...

Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results

January 28, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 28, 2011 /- Awarepoint Corporation, a privately held San Diego-based corporation, today announced it ended 2010 with 91 hospital sites contracted consisting of 45,062,013 million square feet of real-time location system (RTLS) network coverage in U.S. hospitals and 135,265...

Endo Pharmaceuticals and Orion Corporation Begin Novel R & D Collaboration

January 27, 2011 10:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 28, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology. The formation of this R&D...

Varian Medical Systems' Security and Inspection Products Group Receives Largest Single Order for IntellX Systems

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, Jan. 27, 2011 /- Varian Medical Systems (NYSE: VAR ) today announced it has received a $21 million order from U.S. Customs and Border Protection (CBP) for multiple IntellX® cargo container screening systems. The order, booked this month, represents the company's largest...

CareCentrix to Present at Hospital Readmissions Conference

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

HARTFORD, Conn., Jan. 27, 2011 /- CareCentrix, Inc ., the nation's leading provider of home health benefits management services, will present tomorrow at the World Congress' 2nd Annual Leadership Summit on Hospital Re-Admissions in Washington, D.C.  Dr. William Kerr, Chief Medical...

Zimmer Reports Fourth Quarter and 2010 Financial Results

January 27, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Jan. 27, 2011 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter and year ended December 31, 2010.  The Company reported fourth quarter net sales of $1.13 billion, an increase of 2.5% reported and 3.0% constant currency over...

DSM Joins International Response to Flooding in Australia

January 26, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Jan. 27, 2011 /- Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011.  Thousands of residents were affected.  A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading